Genky DrugStores Co., Ltd.
9267Ｇｅｎｋｙ ＤｒｕｇＳｔｏｒｅｓ株式会社
Latest half-year results
First half · fiscal year to 2026-06 · filed 2026-01-30For the first half of the fiscal year to 2026-06: Revenue ¥109.3 billion (+10.6% YoY), Ordinary income ¥5.8 billion (+23.7% YoY), Net income ¥4 billion (+23.0% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥109.3bn | +10.6% |
| Ordinary profit | ¥5.8bn | +23.7% |
| Net profit to owners | ¥4.0bn | +23.0% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/9267/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2026-06-20- Revenue
- ¥220.6bn
- Net income
- ¥7.9bn
- ROE
- 13.8%
- Equity ratio
- 42.0%
- Dividend / share
- ¥13
- Employees
- 1,973
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-06-20 | ¥220.6bn | ¥7.9bn | ¥145.6bn | ¥61.4bn | 13.8% | ¥258.51 | ¥17.0bn |
| 2025-06-20 | ¥200.8bn | ¥7.1bn | ¥127.3bn | ¥53.4bn | 14.2% | ¥232.51 | ¥12.6bn |
| 2024-06-20 | ¥184.9bn | ¥6.3bn | ¥113.9bn | ¥46.7bn | 14.5% | ¥208.21 | ¥13.3bn |
| 2023-06-20 | ¥169.1bn | ¥4.8bn | ¥105.9bn | ¥40.7bn | 12.4% | ¥156.92 | ¥8.8bn |
| 2022-06-20 | ¥154.6bn | ¥4.4bn | ¥97.1bn | ¥36.2bn | 12.9% | ¥145.61 | ¥6.1bn |
Indicators
Computed by us from filings · fiscal year to 2026-06-20| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 13.8 | 74.8 |
| Ordinary margin | 0.0506 | 38.3 |
| Equity ratio, % | 42 | 29.8 |
| Revenue growth | 0.0989 | 69.1 |
| Net income growth | 0.1145 | 47.9 |
| Operating cash flow / assets | 0.1166 | 80.6 |
Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥39.5bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥198m, 1.2% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/9267/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/9267/votingOwnership changes
All companies →- 2026-06-22
Fidelity Management & Research Company LLC raised holdings in Genky DrugStores Co., Ltd. (9267) to 9.22% from 8.10%.
- 2026-06-10
Fidelity Management & Research Company LLC reduced holdings in Genky DrugStores Co., Ltd. (9267) to 8.10% from 8.34%.
- 2026-06-10
FMR LLC filed a correction to a 5% report on Genky DrugStores Co., Ltd. (9267).
- 2024-11-22
Orbis Investment Management Limited disclosed a 5.01% stake in Genky DrugStores Co., Ltd. (9267), crossing the 5% reporting threshold.
- 2024-10-22
FMR LLC raised holdings in Genky DrugStores Co., Ltd. (9267) to 9.38% from 8.34%.
- 2024-10-07
Orbis Investment Management Limited cut holdings in Genky DrugStores Co., Ltd. (9267) to 4.72% from 6.13%, below the 5% threshold.
- 2024-06-21
Orbis Investment Management Limited raised holdings in Genky DrugStores Co., Ltd. (9267) to 6.13% from 5.10%.
- 2023-05-01
Orbis Investment Management Limited disclosed a 5.10% stake in Genky DrugStores Co., Ltd. (9267), crossing the 5% reporting threshold.
5% filings
Large shareholding reports on 9267| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-06-22 | Fidelity Management & Research Company LLC | 9.22% | +1.12pt | — |
| 2026-06-10 | Fidelity Management & Research Company LLC | 8.10% | −0.24pt | — |
| 2026-06-10 | FMR LLC | 9.38% | +1.04pt | — |
| 2024-11-22 | Orbis Investment Management Limited | 5.01% | — | — |
| 2024-10-22 | FMR LLC | 9.38% | +1.04pt | — |
| 2024-10-07 | Orbis Investment Management Limited | 4.72% | −1.41pt | — |
| 2024-06-21 | Orbis Investment Management Limited | 6.13% | +1.03pt | — |
| 2023-05-01 | Orbis Investment Management Limited | 5.10% | — | — |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 3
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| UNIFORM NEXT CO., LTD. 3566 | ¥85m | 0.0% | no |
Held by: 8283 8283, KATO SANGYO CO.,LTD. 9869, ECHO TRADING CO.,LTD. 7427
Purposes, all holdings and mutual flags via /v1/companies/9267/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-06-20| Shareholder | Shares | Ratio |
|---|---|---|
| フジナガインターナショナルキャピタルズ有限会社 | 11,587,600 | 37.98% |
| 日本マスタートラスト信託銀行株式会社（信託口） | 2,538,300 | 8.32% |
| individual holder | 1,740,860 | 5.71% |
| 株式会社日本カストディ銀行（信託口） | 1,439,200 | 4.72% |
| 株式会社エル・ローズ | 1,400,000 | 4.59% |
| individual holder | 963,182 | 3.16% |
| individual holder | 489,824 | 1.61% |
| individual holder | 416,300 | 1.36% |
| ゲンキー従業員持株会 | 386,572 | 1.27% |
| individual holder | 357,500 | 1.17% |
U.S. funds holding 9267
SEC Form N-PORT, reports to 2026-07-3141 U.S. funds held 3,096,697 shares worth $71.8m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Fidelity Low-Priced Stock Fund Fidelity Puritan Trust | 1,740,860 | $40.8m | 0.164% | 2026-07-31 |
| Fidelity Low-Priced Stock K6 Fund Fidelity Puritan Trust | 320,940 | $7.5m | 0.164% | 2026-07-31 |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 217,746 | $5.1m | 0.001% | 2026-07-31 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 155,320 | $3.2m | 0.001% | 2026-06-30 |
| THE JAPANESE SMALL COMPANY SERIES DFA INVESTMENT TRUST CO | 98,200 | $2.3m | 0.057% | 2026-07-31 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/9267
GET /v1/companies/9267/financials
GET /v1/companies/9267/details
GET /v1/companies/9267/segments
GET /v1/companies/9267/voting
GET /v1/companies/9267/tender-offers
GET /v1/companies/9267/indicators
GET /v1/companies/9267/earnings-releases
GET /v1/events?ticker=9267
GET /v1/companies/9267/trades
GET /v1/companies/9267/cross-holdings
GET /v1/companies/9267/brief